ETHERNIADefine fasting before evaluating it
Time-restricted eating, alternate-day restriction and a 4:3 programme are different interventions. Some change timing, some mainly change energy intake, and many change both. An evidence claim should name the actual schedule and comparator instead of treating every period without food as a single treatment.
The 2025 randomized result
A trial randomized 165 adults to 4:3 intermittent restriction or daily restriction, with behavioural support in both groups. At 12 months, the intention-to-treat difference favoured intermittent restriction by 2.89 kg (95% CI 0.14–5.65 kg). Of those randomized, 125 completed the trial. The outcome was body weight, not ageing rate or mortality. [1]
What participants were asked to do
The intermittent group targeted an 80% reduction in energy intake on three nonconsecutive days each week. The daily group targeted a 34% reduction to match the planned weekly deficit. This was not three days of water-only fasting. It was a supported programme, and the result cannot be assumed for every self-directed schedule. [1]
Animals and the translation problem
Dietary-restriction experiments in mice illustrate that feeding interventions can influence survival. They also involve defined diets, genetics and laboratory conditions. The 2024 genetically diverse mouse study examined restriction strategies directly; it does not supply a human lifespan estimate for the programme above. [2]
Why mechanism does not isolate the cause
Even if a programme changes insulin-related measures or other molecular signals, that does not tell us whether timing, total calories, weight loss or adherence drove the result. A useful comparison would match achieved energy intake, not merely intended intake. Without that, a claim about fasting-specific ageing modification remains underdetermined.
Safety belongs to the population
Substantial restriction is a materially different intervention in a well-nourished adult with excess weight than in someone frail or underweight. Medication use, especially glucose-lowering treatment, also changes the context. The trial population and support model should therefore be checked before translating the result. Its design does not establish a universal fasting schedule. [1]
Trial watch and the next decisive comparison
NCT03411356 is the registry for the published programme. A future ageing trial would need adequate nutrition, adherence measurement, function and adverse events, not only weight. Evidence that a timing intervention improves clinical outcomes after controlling for energy intake would materially strengthen the case for a distinct fasting effect. [3]
Sources & study records
- Catenacci et al. (2025). The Effect of 4:3 Intermittent Fasting on Weight Loss at 12 MonthsAnnals of Internal Medicine · Randomized controlled trial
- Di Francesco et al. (2024). Dietary restriction impacts health and lifespan of genetically diverse miceNature · Animal experiment
- Trial investigators (2026). Intermittent Fasting Versus Daily Caloric Restriction for Weight LossClinicalTrials.gov · Registry for published trial
Evidence reviewed 2026-09-16. Registry status can change; follow the linked record for current details.